AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25743731 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD prevention education program (8 sessions over 8 weeks)
Number of subjects: 53
Study 25743731 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 23912069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad with warning about adverse side effects
Number of subjects: 0
Study 23912069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad noting benefits with warning of risky side effects
Number of subjects: 0
Study 23912069 — intervention group
Group type: COMPARATOR
Intervention: Ad noting only benefits
Number of subjects: 0
Study 20869890 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aortic aneurysm repair (EVAR)
Number of subjects: 360
Study 20869890 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 360
Study 19154473 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance scheme for NMI UC patients
Number of subjects: 150
Study 19154473 — intervention group
Group type: COMPARATOR
Intervention: Age- and gender-matched healthy population
Number of subjects: 150
Study 19124904 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 16
Study 19124904 — intervention group
Group type: COMPARATOR
Intervention: No stretching (control)
Number of subjects: 16
Study 15514382 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer consultation preparation package (CCPP)
Number of subjects: 164
Study 15514382 — intervention group
Group type: COMPARATOR
Intervention: Control booklet
Number of subjects: 164
Study 11783834 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic low back pain
Number of subjects: 0
Study 11783834 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic post-traumatic headache
Number of subjects: 0
Study 11783834 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic neck pain
Number of subjects: 0
Study 11783834 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic soft tissue shoulder disorders
Number of subjects: 0
Study 9393429 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased awareness of tobacco use as a risk factor for osseointegration of dental implants
Number of subjects: 0
Study 9393429 — intervention group
Group type: EXPERIMENTAL
Intervention: Discretionary inclusion-exclusion criteria changes
Number of subjects: 0
Study 8481628 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (test preparation)
Number of subjects: 0
Study 8481628 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxipurinol (active metabolite)
Number of subjects: 0
Study 3546751 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic external defibrillators (AEDs)
Number of subjects: 321
Study 3546751 — intervention group
Group type: COMPARATOR
Intervention: Standard defibrillators
Number of subjects: 321
Study 30928927 — intervention group
Group type: EXPERIMENTAL
Intervention: M2M (movement-to-music)
Number of subjects: 0
Study 30928927 — intervention group
Group type: EXPERIMENTAL
Intervention: M2M plus social networking
Number of subjects: 0
Study 30928927 — intervention group
Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 0
Study 30575071 — intervention group
Group type: EXPERIMENTAL
Intervention: A4FTp (T8 criterion)
Number of subjects: 78
Study 30575071 — intervention group
Group type: EXPERIMENTAL
Intervention: SD-OCT (any RNFL parameter p < 1% level)
Number of subjects: 78
Study 30575071 — intervention group
Group type: EXPERIMENTAL
Intervention: FDT (one or more locations missed at p < 5% level)
Number of subjects: 78
Study 26701362 — intervention group
Group type: EXPERIMENTAL
Intervention: Active NMES
Number of subjects: 73
Study 26701362 — intervention group
Group type: COMPARATOR
Intervention: Placebo NMES
Number of subjects: 73
Study 24814528 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone 30 mg/day
Number of subjects: 15
Study 24814528 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 women)
Number of subjects: 15
Study 22747647 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal administration
Number of subjects: 13
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (systemic)
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial dilators
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-psychotic medication
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial infarction
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic heart disease
Number of subjects: 12089
Study 20727660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac dysrhythmia
Number of subjects: 12089
Study 18850554 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpenetrating deep sclerectomy (NPDS) with reticulated hyaluronic acid (SK-GEL) scleral implant
Number of subjects: 93
Study 18850554 — intervention group
Group type: COMPARATOR
Intervention: Punch trabeculectomy (PT)
Number of subjects: 93
Study 18850554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NPDS and PT (with Mitomycin C 0.2 mg/mL applied intraoperatively)
Number of subjects: 93
Study 15911747 — intervention group
Group type: EXPERIMENTAL
Intervention: SphygmoCor central pulse pressure
Number of subjects: 44
Study 15911747 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery pressure
Number of subjects: 44
Study 15911747 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial-to-radial artery pulse pressure amplification
Number of subjects: 44
Study 15911747 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery pulse pressure
Number of subjects: 44
Study 15911747 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration of radial pressure wave with radial instead of brachial artery pressures
Number of subjects: 44
Study 12370858 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 22
Study 12370858 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 22
Study 9923768 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AVM
Number of subjects: 44
Study 9923768 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (cerebral aneurysm or low-grade tumor)
Number of subjects: 44
Study 7594076 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 1012
Study 7594076 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary angioplasty
Number of subjects: 1012
Study 1980278 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (20 mg QD)
Number of subjects: 26
Study 1980278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 7461879 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term alcohol treatment intervention
Number of subjects: 436
Study 7461879 — intervention group
Group type: COMPARATOR
Intervention: Minimal exposure (comparison group)
Number of subjects: 436
Study 31958549 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0
Study 31958549 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 0
Study 31958549 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response
Number of subjects: 0
Study 30588542 — intervention group
Group type: EXPERIMENTAL
Intervention: INTACT method for RNA-sequencing in endosperm
Number of subjects: 0
Study 28953798 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to Mozart's sonata for two pianos in D major, K448, once a day for six months
Number of subjects: 12
Study 28953798 — intervention group
Group type: COMPARATOR
Intervention: Baseline period
Number of subjects: 12
Study 28953798 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 12
Study 25663221 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-V anterior nucleus of the thalamus (ANT) stimulation
Number of subjects: 0
Study 23565581 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 15
Study 23565581 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 15
Study 23565581 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination duloxetine-methadone
Number of subjects: 15
Study 23565581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 21422119 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity during school playtime
Number of subjects: 0
Study 21422119 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical antisocial behavior
Number of subjects: 0
Study 21422119 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal antisocial behavior
Number of subjects: 0
Study 21422119 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent alone
Number of subjects: 0
Study 21422119 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in playground games
Number of subjects: 0
Study 19586568 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg lutein/d (Group L6)
Number of subjects: 37
Study 19586568 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg lutein/d (Group L12)
Number of subjects: 37
Study 19586568 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group Placebo)
Number of subjects: 37
Study 17704981 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 0
Study 14998444 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed System (CS) aspiration
Number of subjects: 26
Study 14998444 — intervention group
Group type: COMPARATOR
Intervention: Open System (OS) aspiration
Number of subjects: 26
Study 11709012 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycloplegic retinoscopy
Number of subjects: 514
Study 11709012 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylindrical error of 1 diopter or more
Number of subjects: 514
Study 11709012 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopia and anisometropia
Number of subjects: 514
Study 9645459 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrahepatic arterial infusion of 131I-radiolabelled anti-HCC monoclonal antibody (Hepama-1 mAb)
Number of subjects: 65
Study 9645459 — intervention group
Group type: COMPARATOR
Intervention: Intrahepatic-arterial chemotherapy (non-RIT group)
Number of subjects: 65
Study 8194689 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK-33 infusion
Number of subjects: 32
Study 8194689 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 32
Study 3364667 — intervention group
Group type: EXPERIMENTAL
Intervention: MAC 0.5 N2O
Number of subjects: 17
Study 3364667 — intervention group
Group type: EXPERIMENTAL
Intervention: MAC 1.0 with volatile anesthetic/N2O
Number of subjects: 17
Study 3364667 — intervention group
Group type: EXPERIMENTAL
Intervention: MAC 0.5 with halothane, enflurane, isoflurane
Number of subjects: 17
Study 29436374 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (ACP) - 12 sessions of acupuncture
Number of subjects: 16
Study 29436374 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + Kinesio Taping (ACP-KT) - 12 sessions of acupuncture plus KT
Number of subjects: 16
Study 27374309 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg once daily
Number of subjects: 256
Study 27374309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 24855155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5145
Study 24855155 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 5145
Study 22383407 — intervention group
Group type: EXPERIMENTAL
Intervention: Active learning project on molecular physiology of sins
Number of subjects: 18
Study 20356615 — intervention group
Group type: EXPERIMENTAL
Intervention: Preperitoneal herniorrhaphy
Number of subjects: 85
Study 20356615 — intervention group
Group type: COMPARATOR
Intervention: Mesh plug herniorrhaphy
Number of subjects: 85
Study 18333862 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc (300 mg b.i.d.)
Number of subjects: 3
Study 18333862 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc (100 mg b.i.d.)
Number of subjects: 3
Study 18333862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 14988451 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (30% energy)
Number of subjects: 20
Study 14988451 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (60% energy)
Number of subjects: 20
Study 11746081 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9771399 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (15 micrograms/kg bolus intravenously, 4 micrograms/kg/h infusion)
Number of subjects: 15
Study 9771399 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study 7825028 — intervention group
Group type: EXPERIMENTAL
Intervention: Handpumps maintained by women
Number of subjects: 30
Study 7825028 — intervention group
Group type: COMPARATOR
Intervention: Handpumps maintained by project workers
Number of subjects: 30
Study 7825028 — intervention group
Group type: EXPERIMENTAL
Intervention: Latrines supervised by women
Number of subjects: 30
Study 7825028 — intervention group
Group type: EXPERIMENTAL
Intervention: Latrines fenced by women
Number of subjects: 30
Study 7825028 — intervention group
Group type: EXPERIMENTAL
Intervention: Latrines emptied by women
Number of subjects: 30
Study 2891886 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir or vidarabine treatment for HSV-1 encephalitis
Number of subjects: 24
Study 2891886 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir or vidarabine treatment for HSV-2 encephalitis
Number of subjects: 24
Study 28732147 — intervention group
Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 202
Study 28732147 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic Health Coaching (THC)
Number of subjects: 202
Study 28732147 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial Incentives (FI)
Number of subjects: 202
Study 28732147 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic Health Coaching + Financial Incentives (THC + FI)
Number of subjects: 202
Study 28437675 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-3135b
Number of subjects: 199
Study 28437675 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-126-5p
Number of subjects: 199
Study 28437675 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-142-5p
Number of subjects: 199
Study 28437675 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-144-5p
Number of subjects: 199
Study 28437675 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-28-3p
Number of subjects: 199
Study 26628527 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG plus cyclosporin A (CsA) (5 mg/kg/day for 5 days; Neoral) plus high-dose IVIG (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Number of subjects: 0
Study 26628527 — intervention group
Group type: COMPARATOR
Intervention: High-dose IVIG alone (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Number of subjects: 0
Study 23800403 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 0.5 mg/kg once daily for up to 14 days
Number of subjects: 52
Study 23800403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 21968669 — intervention group
Group type: EXPERIMENTAL
Intervention: rosacea treatment system (RTS)
Number of subjects: 30
Study 21968669 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS minus metronidazole (RTS‐M)
Number of subjects: 30
Study 21968669 — intervention group
Group type: COMPARATOR
Intervention: metronidazole 0.75% gel plus standard skin care (M+SSC)
Number of subjects: 30
Study 18446086 — intervention group
Group type: EXPERIMENTAL
Intervention: Current intrauterine device users
Number of subjects: 5829
Study 18446086 — intervention group
Group type: COMPARATOR
Intervention: Hormonal contraceptives or condom users
Number of subjects: 5829
Study 18446086 — intervention group
Group type: COMPARATOR
Intervention: Women with miscarriages
Number of subjects: 5829
Study 18446086 — intervention group
Group type: EXPERIMENTAL
Intervention: Current regular smoking
Number of subjects: 5829
Study 18446086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ct positive women
Number of subjects: 5829
Study 16163443 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolon acetonide 40 mg/ml plus lidocaine 2%
Number of subjects: 20
Study 16163443 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 1% (placebo)
Number of subjects: 20
Study 12775743 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-English-speaking Latino parents
Number of subjects: 108
Study 12775743 — intervention group
Group type: COMPARATOR
Intervention: English-speaking minority parents
Number of subjects: 108
Study 12775743 — intervention group
Group type: COMPARATOR
Intervention: English-speaking majority (white) parents
Number of subjects: 108
Study 10962750 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing at 150 beats/min
Number of subjects: 26
Study 10962750 — intervention group
Group type: COMPARATOR
Intervention: DDDR pacing at 175 beats/min
Number of subjects: 26
Study 9099291 — intervention group
Group type: EXPERIMENTAL
Intervention: LCM 1110
Number of subjects: 352
Study 9099291 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 352
Study 9099291 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 352
Study 8472154 — intervention group
Group type: EXPERIMENTAL
Intervention: Transhiatal oesophagectomy
Number of subjects: 67
Study 8472154 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 67
Study 2951805 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (80 micrograms ipratropium bromide + 200 micrograms fenoterol)
Number of subjects: 12
Study 2951805 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol (400 micrograms)
Number of subjects: 12
Study 2951805 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol (200 micrograms)
Number of subjects: 12
Study 2951805 — intervention group
Group type: EXPERIMENTAL
Intervention: disodium cromoglycate (DSCG) (10 mg)
Number of subjects: 12
Study 2951805 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 30986148 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated symbol condition
Number of subjects: 0
Study 30986148 — intervention group
Group type: COMPARATOR
Intervention: Static symbol condition
Number of subjects: 0
Study 29183178 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training for health providers
Number of subjects: 240
Study 29183178 — intervention group
Group type: COMPARATOR
Intervention: Usual care controls
Number of subjects: 240
Study 26766141 — intervention group
Group type: EXPERIMENTAL
Intervention: mongersen 40 mg/day
Number of subjects: 0
Study 26766141 — intervention group
Group type: EXPERIMENTAL
Intervention: mongersen 160 mg/day
Number of subjects: 0
Study 26766141 — intervention group
Group type: EXPERIMENTAL
Intervention: mongersen 10 mg/day
Number of subjects: 0
Study 26766141 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 26766141 — intervention group
Group type: EXPERIMENTAL
Intervention: mongersen (all doses)
Number of subjects: 0
Study 25369357 — intervention group
Group type: EXPERIMENTAL
Intervention: Long Acting Reversible Contraception (LARC) methods
Number of subjects: 65
Study 22594467 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3-4 μg kg(‐1) (C4)
Number of subjects: 60
Study 22594467 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 7-8 μg kg(‐1) (C7)
Number of subjects: 60
Study 22594467 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 60
Study 19859698 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine (0 mg)
Number of subjects: 18
Study 19859698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (5 mg)
Number of subjects: 18
Study 19859698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 18
Study 19859698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (5 mg and 10 mg)
Number of subjects: 18
Study 18022350 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine (0.2 mL without vasoconstrictor)
Number of subjects: 51
Study 18022350 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.2 mL)
Number of subjects: 51
Study 15022521 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental hygienists
Number of subjects: 87
Study 15022521 — intervention group
Group type: COMPARATOR
Intervention: Non-dental hygienists
Number of subjects: 87
Study 11079810 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 U/kg x d ultralente insulin
Number of subjects: 14
Study 9088673 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry recordings
Number of subjects: 0
Study 8224280 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep fundal transfer technique
Number of subjects: 0
Study 8224280 — intervention group
Group type: COMPARATOR
Intervention: Midfundal transfer technique
Number of subjects: 0
Study 3899049 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization with family intervention
Number of subjects: 144
Study 3899049 — intervention group
Group type: COMPARATOR
Intervention: Hospitalization without family intervention
Number of subjects: 144
Study 30370439 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematically aligned TKA
Number of subjects: 14
Study 30370439 — intervention group
Group type: COMPARATOR
Intervention: Mechanically aligned TKA
Number of subjects: 14
Study 28429081 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple grape juice
Number of subjects: 20
Study 28429081 — intervention group
Group type: COMPARATOR
Intervention: Sugar-matched control
Number of subjects: 20
Study 25842051 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based balance exercises (n=35)
Number of subjects: 71
Study 25842051 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance exercises (n=36)
Number of subjects: 71